Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

Riccardo Pinciroli; Simone Checchi; Maurizio Bottiroli; Gianpaola Monti; Giampaolo Casella; Roberto Fumagalli

doi:10.3791/58507

JoVE Journal
Medicine

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Medicine

Endotoxin Activity Assay for the Detection of Whole Blood Endotoxemia in Critically Ill Patients

重症患者における全血エンドトキシア血症の検出に関するエンドトキシン活性アッセイ

Full Text

10,004 Views

06:28 min

June 24, 2019

DOI: 10.3791/58507-v

Riccardo Pinciroli^1,2, Simone Checchi², Maurizio Bottiroli¹, Gianpaola Monti¹, Giampaolo Casella¹, Roberto Fumagalli^1,2

¹Department of Anesthesia and Critical Care,Niguarda Hospital, ²University of Milan-Bicocca Medical School

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This article presents a protocol for measuring endotoxin activity in human whole blood samples at the bedside. The Endotoxin Activity Assay serves as a quick and reliable biomarker for critically ill patients with sepsis.

Key Study Components

Area of Science

Clinical diagnostics
Sepsis research
Biomarker development

Background

Sepsis can result in multi-organ failure and death.
Endotoxin is a key component of gram-negative bacteria.
Elevated endotoxin levels may indicate a higher risk of severe disease.
Early detection of endotoxin can aid in patient management.

Purpose of Study

To provide a bedside protocol for endotoxin activity measurement.
To evaluate the assay's effectiveness as a biomarker in septic patients.
To improve clinical outcomes through early detection and intervention.

Methods Used

Endotoxin Activity Assay performed on whole blood samples.
Assessment of circulating endotoxin levels in patients.
Comparison of assay results with clinical outcomes.
Implementation in a critical care setting.

Main Results

The assay provides rapid results for endotoxin activity.
Higher endotoxin levels correlate with severe sepsis outcomes.
Early identification of endotoxemia can guide treatment decisions.
Potential for improved patient management in septic shock.

Conclusions

The Endotoxin Activity Assay is a valuable tool in critical care.
It may enhance the early detection of septic patients at risk.
Further studies are needed to confirm its clinical utility.

Frequently Asked Questions

What is the Endotoxin Activity Assay?

It is a test used to measure endotoxin levels in blood, indicating the severity of sepsis.

How does endotoxin affect patients with sepsis?

Elevated endotoxin levels can lead to a higher risk of multi-organ failure and poor outcomes.

Can the assay be performed at the bedside?

Yes, the assay is designed for bedside use, providing quick results.

What are the implications of early endotoxin detection?

Early detection can prompt timely and intensive treatment, improving patient outcomes.

Is the Endotoxin Activity Assay widely used?

Its use is growing in critical care settings, but further validation is needed.

What are the limitations of the assay?

The assay's effectiveness may vary based on patient condition and timing of the test.

我々は、本明細書を、ヒト全血試料のエンドトキシン活性をベッドサイドで測定するプロトコルを提示する。エンドトキシン活性アッセイは、実行するための簡単なテストであり、敗血症の重症患者に有用なバイオマーカーである可能性があります。

敗血症は多臓器不全や死を引き起こす可能性があります。内毒素はグラム陰性菌の基本的な成分である。内毒素の循環レベルの上昇は、より重篤な疾患を発症するリスクが高い患者を特定する可能性があります。

このEndotoxin活性アッセイは、全身性内毒素症のシンプルで迅速かつ信頼性の高いバイオマーカーとして使用できます。この毒素の早期発見は、敗血症性ショック患者を治療する臨床医を助けるかもしれない。敗血症性ショックを受けた患者では、急速に進化する状態の早期同定は、より迅速かつ集中的な生命維持療法を促し、より良い結果につながる可能性がある。

View the full transcript and gain access to thousands of scientific videos

Explore More Videos

医学問題148 エンドトキシン活性敗血症ショックリポ多糖化学発光好中球